Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABMD

Abiomed (ABMD) Stock Price, News & Analysis

Abiomed logo

About Abiomed Stock (NASDAQ:ABMD)

Advanced Chart

Key Stats

Today's Range
$381.02
$381.02
50-Day Range
$377.20
$381.30
52-Week Range
$219.85
$381.99
Volume
258 shs
Average Volume
611,028 shs
Market Capitalization
$17.18 billion
P/E Ratio
65.47
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abiomed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

ABMD MarketRank™: 

Abiomed scored higher than 31% of companies evaluated by MarketBeat, and ranked 755th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Abiomed.

  • Earnings Growth

    Earnings for Abiomed are expected to grow by 19.21% in the coming year, from $4.58 to $5.46 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Abiomed is 65.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Abiomed is 65.47, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.66.

  • Price to Earnings Growth Ratio

    Abiomed has a PEG Ratio of 3.33. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Abiomed has a P/B Ratio of 11.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ABMD.
  • Dividend Yield

    Abiomed does not currently pay a dividend.

  • Dividend Growth

    Abiomed does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ABMD.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Abiomed this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Abiomed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.50% of the stock of Abiomed is held by insiders.

  • Percentage Held by Institutions

    94.48% of the stock of Abiomed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Abiomed's insider trading history.
Receive ABMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abiomed and its competitors with MarketBeat's FREE daily newsletter.

ABMD Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Abiomed Heart Pumps Linked to 49 Deaths
See More Headlines

ABMD Stock Analysis - Frequently Asked Questions

Abiomed, Inc. (NASDAQ:ABMD) posted its quarterly earnings results on Wednesday, October, 27th. The medical equipment provider reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.98 by $0.05. The firm's quarterly revenue was up 18.3% compared to the same quarter last year.
Read the conference call transcript
.

Abiomed subsidiaries include these companies: ECP Entwicklungsgesellschaft mbH, Impella Cardiosystems, ABD Holding Company, ABIOMED Athlone Ltd, ABIOMED Australia Pte. Ltd, ABIOMED Europe, ABIOMED Japan KK, and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abiomed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
10/27/2021
Today
7/06/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ABMD
Employees
2,003
Year Founded
1981

Profitability

Trailing P/E Ratio
65.47
Forward P/E Ratio
83.19
P/E Growth
3.33
Net Income
$136.51 million
Pretax Margin
31.76%

Debt

Sales & Book Value

Annual Sales
$1.03 billion
Cash Flow
$5.09 per share
Price / Cash Flow
74.88
Book Value
$33.03 per share
Price / Book
11.54

Miscellaneous

Free Float
43,964,000
Market Cap
$17.18 billion
Optionable
Optionable
Beta
1.40

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:ABMD) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners